Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of DA-8031 for premature ejaculation. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• DA-8031

Snippet

Sponsor: Dong-A Pharmaceutical Co., Ltd. | Conditions: Premature Ejaculation | Phase 2 | Status: UNKNOWN